Efficacy and safety of telaprevir (TVR) triple therapy in a 'real-life' cohort of 102 patients with HCV genotype 1: interim analysis after 24 weeks of treatment.
| Image |  |
|---|---|
| Description | scientific article published on 5 August 2013 |
| Author/s |
author: Christoph R. Werner |
| Publication date | August 5, 2013 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |